Clinical Research Directory
Browse clinical research sites, groups, and studies.
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
Sponsor: Rajesh Narendran
Summary
This study uses \[11C\]NPA positron emission tomography (PET) and a d-amphetamine challenge to image amphetamine induced dopamine release in the striatum in subjects with cocaine use disorders (CUD). Amphetamine-induced dopamine release data from this study will be correlated with \[11C\]NOP-1A VT measured at baseline in the midbrain. \[11C\]NOP-1A PET data will be used from aim 1 (see, Study Record: Imaging CRF X NOP interactions in Cocaine Use Disorders)
Official title: [C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2021-01-31
Completion Date
2028-09-01
Last Updated
2025-06-05
Healthy Volunteers
No
Conditions
Interventions
Baseline [C-11]NPA PET Scan
Radiotracer
d-amphetamine
Oral, 0.5 mg/Kg
Post-amphetamine [C-11]NPA PET Scan
Radiotracer
Locations (1)
University of PIttsburgh
Pittsburgh, Pennsylvania, United States